Observational studyFrontiers in immunology2025

Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy-a single center experience.

Anna Rudzińska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.